Bio pharmazeutika, or bio-based medicines, are created using living cells. They are used to treat a variety of diseases and conditions. They are the most recent generation of drugs, and their creation requires many technical skills. They are made from various sources, including pig cells, human cells and plants cells. Gene technology is also utilized to make them.
Traditional medications are manufactured using various chemical processes, whilst biopharmazeutika are produced using biological processes which involve living organisms, such as bacteria and yeasts. They can also be created by using cell extracts, such as fibroblasts or animal cells. The benefit of this kind of medicine is that it can be made faster than traditional medications and can be adapted to the molecular and genetic profile of the individual patient, known as personalised medicine.
Contrary to traditional pharmaceuticals, which mainly affect the body system in general biopharmazeutika can interact with specific cell pathways. This means they are able to specifically treat cancers and other conditions more effectively than conventional medications. Some examples include monoklonale Antikorper and Rituximab which is used to treat rheumatoid arthritis as well as certain types of breast cancer by binding specifically to the HER2 protein on cancer cells and stopping them from growing. Immunotherapies, such as vaccines, also fall into this category as they stimulate the immune system to create antibodies against certain diseases.
StudySmarter provides a comprehensive range of online learning materials, including interactive Karteikarten, umfassende Lehrbuchlosungen und detaillierter Explanations, sowie umfangreiche Test-Prufmaterialien fur die verschiedenen Fachleitlinien www.genotec-frankfurt.de/bio-pharmazeutika-werden-zu-einer-anerkannten-form-der-alternativmedizin/ auf verschiedenste Stufen. Diese Lernmaterialien helfen Schulern weltweit, ihren Erfolg bei den verschiedenen Tests und Prufungen wie GCSE, A Level, SAT, ACT oder Abitur zu verbessern.
